About Genesort
Genesort is a company based in Herzliya (Israel) founded in 2013 was acquired by AID Partners in May 2017. Genesort operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Singulariteam
& 1 more
-
Employee Count
Not available
-
Acquired by
AID Partners
(May 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genesort
Investors in Genesort
Genesort has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Singulariteam and AID Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology investments in Israel are targeted by Singulariteam.
|
Locked | Locked | Locked | |
|
PE firm invests globally
|
Locked | Locked | Locked |
Investor details for Genesort
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genesort
Investment portfolio details for Genesort
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genesort
Detailed financials for Genesort
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genesort Comparisons
Peer comparison for Genesort
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genesort
Genesort operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
Detailed competitors of Genesort
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genesort
Complete news archive for Genesort
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genesort
Genesort was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Genesort is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Genesort was founded in 2013 in Herzliya, Israel, within the molecular diagnostics sector. Operations center on integrating genomics with personalized medicine for cancer and hereditary diseases. Genetic DNA profiles of patients are analyzed using advanced technologies, supporting physicians in identifying treatments matched to individual genetic characteristics. Diagnostic services are delivered to facilitate precise and safe therapeutic decisions.
Genesort's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
Genesort has 2 investors. Key investors include Singulariteam, and AID Partners.